Side areas

Immune Technology Steyr

Medical Technology/Digital Health 2022

The main objectives are the development of antiviral products such as mouth-nose sprays made from an aerosol solution or lozenges as comprehensive protection against viruses and bacteria. The active ingredient is a human lectin, which occurs naturally (banana lectin) as well as can be produced artificially and has manose binding properties. This is to prevent a virus from being able to communicate with a cell at all. In this way, the MBL protein is supposed to prevent the virus from entering the cell and thus avoid infection. This has already been confirmed in laboratory and animal experiments (POC).

The USP concerns the ease of use as a nasal spray, quick action and the handiness as an on-the-go product that can be reused at any time, ready to hand. It provides additional safety in public, so that conventional protective masks can increasingly be dispensed with.

Services / Products:
Antiviral nasal and oral spray as an aerosol solution as well as lozenges and antiviral chewing gums.

Founder:

  • Mag. Peter Weigl
  • Dr. Martin Schifko
  • Prof. Dr. Alireza Eslamian
tech2b_its_team.jpg Picture: Hermann Wakolbinger

Facts

CEO
Mag. Peter Weigl, Dr. Martin Schifko & Prof. Dr. Alireza Eslamian
Project start: 2022
Industry: Medical Technology / Digital Health
Employees: 1
Markets: EU, USA, Asia
Immune Technology Steyr
Schlüsselhofgasse 42 Top 8
4400 Steyr
WordPress Cookie Plugin by Real Cookie Banner